Cécile Alanio, MD, PhD Parker Bridge Fellow Biography Cécile is a former postdoc in the Wherry Lab at the University of Pennsylvania. During her postdoc, she worked on samples from COVID patients, as well as PDAC, glioblastoma, lymphoma and CAR T cancer patients with a translational approach. She is now deputy director of the Clinical Immunology Laboratory at Institut Curie in Paris, France, where she helps coordinate the immunomonitoring of cancer patients. Cécile also is a Parker Bridge Scholar in the independent phase in the U932 (Amigorena team). Her T Cell Inspection (TCI) team studies T-cell biology in human health and disease. Her focus is on solid tumors and CAR T-cell profiling. Cécile is an active collaborator of the Wherry Lab the and the Parker Institute for Cancer Immunotherapy (PICI). Education & Training 2011: Université Paris 5, Paris, France, MD, Medicine 2015: Institut Pasteur, Paris, France, Ph.D., Immunology Awards & Honors 2019: Parker Bridge Fellow 2018: Philippe Foundation Award 2017 : Institut National Cancer Association, support for training young doctors in translational research in oncology (Postdoc) 2017: Fondation Bettencourt Schueller Young Researcher Award 2017: Project granted with Seal of Excellence at EU H2020 Marie Curie Individual (Global) Fellowship (TURBO project) 2016: Awarded among the 300 best talents 2016 L’Oréal-UNESCO Pour les Femmes et la Science 2011: Institut National Cancer Association, support for training young doctors in translational research in oncology (PhD) 2008: Institut National Cancer Association, support for training young doctors in translational research in oncology (Master)